ENDOCYTE INC's ticker is ECYT and the CUSIP is 29269A102. A total of 101 filers reported holding ENDOCYTE INC in Q3 2014. The put-call ratio across all filers is 2.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $44,000 | -18.5% | 29,221 | +39.5% | 0.00% | – |
Q1 2017 | $54,000 | -54.6% | 20,951 | -55.3% | 0.00% | – |
Q4 2016 | $119,000 | +50.6% | 46,828 | +84.2% | 0.00% | – |
Q3 2016 | $79,000 | -26.2% | 25,428 | -23.9% | 0.00% | – |
Q2 2016 | $107,000 | +35.4% | 33,417 | +31.4% | 0.00% | – |
Q1 2016 | $79,000 | -22.5% | 25,428 | 0.0% | 0.00% | – |
Q4 2015 | $102,000 | -60.5% | 25,428 | -54.9% | 0.00% | -100.0% |
Q3 2015 | $258,000 | -11.9% | 56,428 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $293,000 | -19.7% | 56,428 | -3.2% | 0.00% | 0.0% |
Q1 2015 | $365,000 | +29.0% | 58,312 | +29.8% | 0.00% | 0.0% |
Q4 2014 | $283,000 | +3.7% | 44,925 | 0.0% | 0.00% | 0.0% |
Q3 2014 | $273,000 | -6.8% | 44,925 | +0.9% | 0.00% | 0.0% |
Q2 2014 | $293,000 | -62.0% | 44,536 | +37.3% | 0.00% | -75.0% |
Q1 2014 | $772,000 | +120.6% | 32,442 | -0.8% | 0.00% | +300.0% |
Q4 2013 | $350,000 | -21.2% | 32,703 | -1.7% | 0.00% | -50.0% |
Q3 2013 | $444,000 | +49.0% | 33,278 | +46.5% | 0.00% | 0.0% |
Q2 2013 | $298,000 | – | 22,723 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 3,364,648 | $14,401,000 | 1.20% |
Asymmetry Capital Management, L.P. | 81,484 | $349,000 | 0.47% |
PFM Health Sciences, LP | 3,441,594 | $14,730,000 | 0.35% |
Perceptive Advisors | 1,451,700 | $6,213,000 | 0.21% |
Leisure Capital Management | 28,304 | $121,000 | 0.10% |
Cribstone Capital Management, LLC | 47,349 | $203,000 | 0.10% |
EAM Investors, LLC | 98,034 | $420,000 | 0.08% |
SG3 Management, LLC | 32,500 | $139,000 | 0.05% |
Baker Brothers Advisors | 1,087,323 | $4,654,000 | 0.04% |
Alpine Global Management, LLC | 33,675 | $144,000 | 0.03% |